Selepressin, a novel selective vasopressin V(1A) agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

por Russell, James A., Vincent, Jean-Louis, Kjølbye, Anne Louise, Olsson, Håkan, Blemings, Allan, Spapen, Herbert, Carl, Peder, Laterre, Pierre-Francois, Grundemar, Lars
Publicado 2017

A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock*

por He, Xinrong, Su, Fuhong, Taccone, Fabio Silvio, Laporte, Régent, Kjølbye, Anne Louise, Zhang, Jing, Xie, Keliang, Moussa, Mouhamed Djahoum, Reinheimer, Torsten Michael, Vincent, Jean-Louis
Publicado 2016

Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure

por Mebazaa, Alexandre, Laterre, Pierre François, Russell, James A., Bergmann, Andreas, Gattinoni, Luciano, Gayat, Etienne, Harhay, Michael O., Hartmann, Oliver, Hein, Frauke, Kjolbye, Anne Louise, Legrand, Matthieu, Lewis, Roger J., Marshall, John C., Marx, Gernot, Radermacher, Peter, Schroedter, Mathias, Scigalla, Paul, Stough, Wendy Gattis, Struck, Joachim, Van den Berghe, Greet, Yilmaz, Mehmet Birhan, Angus, Derek C.
Publicado 2016

Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant h...

por Pickkers, Peter, Angus, Derek C, Arend, Jacques, Bellomo, Rinaldo, van den Berg, Erik, Bernholz, Juliane, Bestle, Morten, Broglio, Kristine, Carlsen, Jan, Doig, Christopher J, Ferrer, Ricard, Joannidis, Michael, Francois, Bruno, Doi, Kent, Kellum, John A, Laterre, Pierre-François, Liu, Kathleen, Mehta, Ravindra L, Murray, Patrick T, Ostermann, Marlies, Pettilä, Ville, Richards, Sharon, Young, Paul, Zarbock, Alexander, Kjølbye, Anne Louise
Publicado 2023